{"gene":"RAPGEF3","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2002,"finding":"EPAC1 (RAPGEF3) functions as a cAMP-activated guanine nucleotide exchange factor (GEF) for Rap1; a selective cAMP analogue (8CPT-2Me-cAMP) activates Epac but not PKA, demonstrating that cAMP-induced Rap1 activation and ERK regulation are independent processes.","method":"Selective cAMP analogue pharmacology (8CPT-2Me-cAMP), in vitro and cell-based GEF assays, ERK activity measurements","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 — rational drug design with in vitro and in vivo validation, replicated across multiple cell lines","pmids":["12402047"],"is_preprint":false},{"year":2003,"finding":"Epac activation requires cAMP binding that releases inhibitory interaction between the C-terminal helical lid of the cAMP-binding domain and the catalytic region; mutational analysis of the lid region modulates activation potency of cAMP analogues.","method":"Mutational analysis of Epac cAMP-binding domain lid region, in vitro GEF activity assays with cAMP analogues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structure-guided mutagenesis combined with in vitro enzymatic assays","pmids":["12888551"],"is_preprint":false},{"year":2004,"finding":"EPAC1 directly interacts with R-Ras and catalyzes GDP/GTP exchange on R-Ras in vitro; Epac-mediated R-Ras activation downstream of Gs-coupled receptors specifically controls phospholipase D stimulation.","method":"In vitro GEF assay (recombinant Epac1 + R-Ras), dominant-negative Epac1 mutant, siRNA depletion of Epac1, Rap GTPase-activating protein II expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro GEF reconstitution plus multiple genetic loss-of-function approaches","pmids":["16754664"],"is_preprint":false},{"year":2004,"finding":"EPAC1 interacts with the light chain 2 (LC2) of microtubule-associated protein 1A (MAP1A) via its cAMP-binding domain; this interaction was confirmed by two-hybrid, co-immunoprecipitation, and GST pull-down assays.","method":"Yeast two-hybrid screen, co-immunoprecipitation, GST pull-down assay, immunolocalization in HEK293 and COS1 cells","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2/3 — reciprocal co-IP and pull-down with domain mapping, single lab","pmids":["15202935"],"is_preprint":false},{"year":2004,"finding":"Epac1 activates H-Ras and subsequently ERK1/2 via a pathway involving Rap2B and phospholipase C-epsilon (PLC-ε), leading to intracellular Ca2+ increase that activates a Ca2+-sensitive Ras-GEF (possibly RasGRP1); dominant-negative Rap2B and RapGAPII block this pathway.","method":"Dominant-negative mutants (H-Ras, Rap2B), Epac-selective cAMP analogue, constitutively active Rap2B, cAMP-binding-deficient Epac1 mutant, ERK1/2 activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal genetic tools (dominant-negatives, constitutively active mutants, binding-deficient mutant) with functional readouts","pmids":["15319437"],"is_preprint":false},{"year":2005,"finding":"In IB4+ DRG nociceptors, cAMP signals to PKCε via Epac (not PKA), with Epac acting upstream of phospholipase C and PLD, both required for PKCε translocation and activation; this pathway mediates cAMP-induced mechanical hyperalgesia.","method":"Selective Epac agonist, pharmacological inhibition of PLC/PLD/PKCε, behavioral pain model, cultured DRG neurons","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — pharmacological pathway dissection with in vitro and in vivo behavioral validation","pmids":["15987941"],"is_preprint":false},{"year":2005,"finding":"Epac activation in cardiomyocytes induces hypertrophy through Ca2+-dependent activation of Rac, calcineurin/NFAT pathway; Rac and calcineurin inhibition blunts the Epac-induced hypertrophic response.","method":"Epac-selective cAMP analogue, dominant-negative Rac, calcineurin inhibitor, NFAT reporter assay in neonatal cardiomyocytes","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal pharmacological and genetic inhibition approaches with defined phenotypic readout","pmids":["16269655"],"is_preprint":false},{"year":2006,"finding":"Epac1 and Epac2 co-immunoprecipitate with full-length sulphonylurea receptor 1 (SUR1) in HEK cells; Epac-selective cAMP analogues inhibit ATP-sensitive K+ (KATP) channel function in human beta cells and INS-1 cells, an effect abolished by dominant-negative Epac1.","method":"Co-immunoprecipitation (Epac + SUR1), patch-clamp electrophysiology, dominant-negative Epac1 transfection, Epac-selective vs. PKA-selective cAMP analogues","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1/2 — direct protein interaction (Co-IP) combined with functional electrophysiology and dominant-negative validation","pmids":["16613879"],"is_preprint":false},{"year":2006,"finding":"Epac activation triggers intracellular Ca2+ mobilization via ryanodine-sensitive stores and apical exocytotic insertion of aquaporin-2 (AQP2) in inner medullary collecting duct (IMCD), independent of PKA.","method":"Confocal fluorescence microscopy in perfused IMCD, Epac-selective cAMP agonist, ryanodine receptor blocker, PKA inhibitors, immunolocalization of AQP2","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — live imaging with pharmacological pathway dissection, single lab","pmids":["16684923"],"is_preprint":false},{"year":2007,"finding":"Anthrax edema toxin-generated cAMP inhibits endothelial cell chemotaxis via Epac and Rap1; activated Epac or Rap1 induces cytoskeletal changes and blocks chemotaxis; ET also induces transcription of Epac2 and MR-GEF/RapGEF5.","method":"cAMP analogue pharmacology, constitutively active Epac/Rap1 overexpression, chemotaxis assays, cytoskeletal imaging","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function with functional cellular readout, single lab","pmids":["17491018"],"is_preprint":false},{"year":2007,"finding":"Pharmacological activation of Epac1 increases Rap1 activity, stimulates beta1- and beta2-integrin-dependent adhesion and migration of endothelial progenitor cells, rapidly increases lateral mobility and affinity of beta1-integrins, and enhances homing to ischemic muscle in vivo.","method":"Epac-selective cAMP analogue, Rap1 activity assay (pulldown), integrin affinity/avidity assays, hind limb ischemia mouse model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vitro assays plus in vivo validation","pmids":["18032709"],"is_preprint":false},{"year":2008,"finding":"Epac1 mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy through Ras (not Rap1), calcineurin, and CaMKII in a PKA-independent manner; Epac1 knockdown reduces beta-AR-induced hypertrophic gene program.","method":"Epac-selective analogue, Epac1 siRNA knockdown, Ras/Rap1 activity assays, calcineurin and CaMKII inhibitors, adult ventricular myocytes","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — pharmacological + genetic (siRNA) + epistatic pathway dissection in primary cardiomyocytes","pmids":["18323524"],"is_preprint":false},{"year":2008,"finding":"Epac forms a complex with Akt and PP2A; cAMP activates Epac-associated PP2A in a PKA- and Rap1-dependent manner, leading to Akt dephosphorylation; both Epac- and PKA-specific analogues synergistically regulate this Epac-Rap1b-PP2A module controlling Akt.","method":"Co-immunoprecipitation (Epac-Akt-PP2A complex), Epac-selective vs. PKA-selective cAMP analogues, dominant-negative Epac, dominant-negative PP2A, phosphatase activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct protein complex identification by Co-IP with functional phosphatase activity assay and multiple pathway perturbations","pmids":["18550542"],"is_preprint":false},{"year":2008,"finding":"AKAP150 forms complexes with PKA, PKB/Akt, and Epac in neurons; Epac activation increases PKB/Akt phosphorylation in a Rap-dependent manner, and this effect is mediated through AKAP150-anchored signaling; Epac2 siRNA preferentially blocks this Epac-mediated Akt phosphorylation.","method":"Co-immunoprecipitation (AKAP150 with Epac/PKA/Akt), Epac-selective analogue, siRNA knockdown of Epac1/Epac2, PKA-anchoring-deficient AKAP150 mutant, AKAP-disrupting peptides","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus genetic (siRNA) and dominant-negative approach in primary neurons","pmids":["18565730"],"is_preprint":false},{"year":2008,"finding":"Epac activation induces ventricular arrhythmias in intact murine hearts associated with altered intracellular Ca2+ homeostasis in ventricular myocytes; these effects are reduced by CaMKII inhibition, placing CaMKII downstream of Epac in cardiac Ca2+ dysregulation.","method":"Langendorff-perfused mouse heart, monophasic action potential recording, programmed electrical stimulation, fluorescence Ca2+ imaging, CaMKII inhibitor (KN-93), Epac-selective cAMP analogue","journal":"Pflugers Archiv","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular mechanism (CaMKII) with intact organ functional readout, single lab","pmids":["18600344"],"is_preprint":false},{"year":2008,"finding":"Epac (RAPGEF3) promotes DRG neurite outgrowth and regeneration on spinal cord tissue in a cAMP-dependent, PKA-independent manner; siRNA knockdown of Epac reduces neurite outgrowth and prevents cAMP-elevation-induced growth; asymmetric Epac activation promotes attractive growth cone turning.","method":"Epac-selective cAMP analogue, siRNA knockdown, neurite outgrowth assays on spinal cord substrate, growth cone turning assay","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 2 — pharmacological activation plus genetic knockdown with defined neurite outgrowth and guidance readouts","pmids":["18583150"],"is_preprint":false},{"year":2009,"finding":"Epac stimulates GDP/GTP exchange on Rap1 upstream of PLC, leading to IP3-dependent Ca2+ mobilization from acrosomal stores during sperm exocytosis; Epac also indirectly activates Rab3A (not via direct GEF activity) via a pathway downstream of soluble adenylyl cyclase/cAMP/Epac but not Rap1.","method":"Recombinant Epac in vitro GEF assay on Rab3A and Rap1, Epac-selective cAMP analogue, PLC inhibitors, Ca2+ mobilization measurements in human sperm","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution (recombinant Epac GEF assay) plus pharmacological pathway dissection","pmids":["19546222"],"is_preprint":false},{"year":2009,"finding":"Epac activation reduces Ca2+ transient amplitude and increases myofilament Ca2+ sensitivity in cardiomyocytes; Epac increases phosphorylation of cardiac Troponin I and MyBP-C via PKC and CaMKII (not PKA), constituting a novel regulator of myofilament function.","method":"Epac-selective analogue, constitutively active Epac in vivo infection, permeabilized cardiomyocyte Ca2+ sensitivity assays, PKC/CaMKII inhibitors, sarcomeric protein phosphorylation analysis","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — pharmacological + genetic (constitutively active Epac) + biochemical phosphorylation assays with defined functional readouts","pmids":["19666481"],"is_preprint":false},{"year":2009,"finding":"Epac1 activates H-Ras in neonatal cardiac myocytes via a PLC/IP3R/Ca2+ cascade downstream of Rap; Epac1 activation induces HDAC4 nuclear export and, in the presence of HDAC4, HDAC5 also becomes responsive; CaMKII mediates MEF2 activation, linking Epac to pro-hypertrophic gene expression.","method":"RapGAP overexpression, PLC/IP3R inhibitors, constitutively active Epac1, HDAC4/5 translocation assays, CaMKII inhibitor, MEF2 reporter in cardiac myocytes","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 — pathway dissection with multiple inhibitors and genetic tools plus functional gene expression readouts","pmids":["20576488"],"is_preprint":false},{"year":2009,"finding":"EPAC1 promotes angiogenesis in endothelial cells via Akt/eNOS/NO signaling and ERK phosphorylation in a PI3K-dependent, PKA-independent manner; siRNA knockdown of Epac1 suppresses Akt/eNOS phosphorylation and angiogenesis without affecting CREB phosphorylation or VEGF expression.","method":"Epac-selective cAMP analogue (8CPT-2Me-cAMP), Epac1 siRNA knockdown, phosphorylation assays, in vitro angiogenesis assay, in vivo neovascularization","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 — pharmacological + genetic (siRNA) with multiple orthogonal functional readouts including in vivo","pmids":["19385062"],"is_preprint":false},{"year":2009,"finding":"Epac1 mediates cAMP-induced inhibition of migration and proliferation in prostate carcinoma cells through inhibition of MAP kinase and RhoA signaling, while activating Rap1.","method":"Epac-selective cAMP analogue, Rap1/RhoA pulldown assays, MAP kinase immunoblotting, scratch migration assay, [3H]thymidine incorporation, phalloidin cytoskeleton staining","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological activation with multiple biochemical and functional readouts, single lab","pmids":["19920825"],"is_preprint":false},{"year":2009,"finding":"Epac increases melanoma cell migration via syndecan-2 translocation to lipid rafts regulated by tubulin polymerization through the Epac/PI3K pathway, and via increased NDST-1 expression leading to enhanced heparan sulfate production.","method":"Epac-specific agonist, Epac overexpression, Epac siRNA, syndecan-2 localization assay, in vivo lung colonization model","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological + genetic approaches with defined mechanistic molecular intermediates, single lab","pmids":["19657062"],"is_preprint":false},{"year":2010,"finding":"Epac1 genetic disruption in mice abolishes 3-nitropropionic acid-induced neuronal apoptosis in vivo; Epac promotes cortical neuron-specific apoptosis by transcriptionally upregulating Bim expression, and Bim silencing attenuates Epac-induced neuronal apoptosis.","method":"Epac1 knockout mice, 3-NP in vivo model, Bim siRNA, TUNEL staining, DNA fragmentation assay, Bim mRNA quantification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO mouse with in vivo readout plus siRNA rescue in vitro","pmids":["20516079"],"is_preprint":false},{"year":2011,"finding":"Taurocholate-induced hepatocyte polarization proceeds through a cAMP-Epac-MEK-Rap1-LKB1-AMPK pathway; inhibition of Epac downstream targets Rap1 and MEK blocks taurocholate-induced bile canalicular network formation.","method":"Pharmacological inhibitors of adenylyl cyclase, PKA, Epac, Rap1, MEK; kinase activation assays (MEK, LKB1, AMPK); rat hepatocyte sandwich cultures; bile canaliculi imaging","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — multi-step epistasis using specific inhibitors at each node of the pathway with defined morphological readout","pmids":["21220320"],"is_preprint":false},{"year":2011,"finding":"RAPGEF3 is localized to the acrosome and subacrosomal ring in equine sperm; activation of RAPGEF3/RAPGEF4 induces acrosomal exocytosis in capacitated sperm and prevents hyperpolarization of the sperm plasma membrane, identifying a role for RAPGEF3 in membrane potential regulation during fertilization.","method":"Indirect immunofluorescence localization, RAPGEF3/4-selective cAMP analogue (8pCPT), acrosomal exocytosis assay, membrane potential measurements","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization plus functional pharmacology, single lab","pmids":["21471298"],"is_preprint":false},{"year":2012,"finding":"The Epac-Rap1 signaling pathway controls cAMP-mediated Weibel-Palade body (WPB) exocytosis in endothelial cells; siRNA knockdown of Epac1 abolishes epinephrine-induced Rap1 activation and reduces WPB exocytosis; Rap1GAP overexpression or Rap1 siRNA also reduces epinephrine-induced exocytosis.","method":"siRNA knockdown of Epac1 and Rap1, Rap1GAP overexpression, WPB exocytosis assay, Rap1 activation pulldown, epinephrine stimulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic loss-of-function approaches with defined cellular functional readout","pmids":["22511766"],"is_preprint":false},{"year":2012,"finding":"EPAC1 plays an important role in pancreatic cancer cell migration and invasion; the EPAC-specific inhibitor ESI-09 blocks intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion.","method":"EPAC-specific inhibitor (ESI-09), Rap1 activation assay, Akt phosphorylation, migration and invasion assays, insulin secretion assay","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibitor with multiple biochemical readouts, single lab","pmids":["23066090"],"is_preprint":false},{"year":2012,"finding":"CE3F4, a tetrahydroquinoline Epac1 inhibitor, blocks Epac1 GEF activity toward Rap1 in cell-free systems and intact cells without inhibiting PKA or directly affecting Rap1 GDP exchange; kinetic analysis indicates uncompetitive inhibition with respect to Epac1 agonists.","method":"Cell-free GEF assay, intact cell Rap1 activation assay, PKA holoenzyme activity assay, kinetics of inhibition, structure-activity relationship analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — cell-free GEF reconstitution with mechanistic kinetic analysis and SAR","pmids":["23139415"],"is_preprint":false},{"year":2009,"finding":"Epac activation induces vascular relaxation in rat mesenteric arteries through two mechanisms: (1) increasing ryanodine receptor-dependent Ca2+ sparks to activate BKCa channels in smooth muscle, and (2) endothelium-dependent SKCa/IKCa channel activation and NOS stimulation.","method":"Isometric tension recording, patch-clamp (STOCs), Ca2+ spark imaging (Fluo-4), iberiotoxin, apamin, TRAM-34, L-NAME, ryanodine, endothelium removal","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple electrophysiological and imaging approaches with pharmacological pathway dissection","pmids":["23959673"],"is_preprint":false},{"year":2009,"finding":"Epac activation mediates hinge-motion-dependent conformational change in the enzyme: substitution of conserved phenylalanine 435 with glycine (F435G) in Epac2 yields constitutively active enzyme without cAMP, while F435W impedes hinge motion and dramatically reduces catalytic activity.","method":"Site-directed mutagenesis, in vitro GEF activity assay, small angle X-ray scattering (SAXS) for structural parameters","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with in vitro enzymatic assay and SAXS structural validation","pmids":["19553663"],"is_preprint":false},{"year":2015,"finding":"Phospholipase Cε (PLCε) is required for the acrosome reaction downstream of Rap1 and upstream of intra-acrosomal Ca2+ mobilization; the cAMP/Epac/Rap1/PLCε/IP3 cascade constitutes the signaling module for acrosomal Ca2+ release during sperm exocytosis.","method":"TAT-cAMP sponge (sequester endogenous cAMP), siRNA for PLCε, Rap1-GTP pulldown, Ca2+ mobilization measurement, Rab3-GTP pulldown","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — novel molecular tool (TAT-cAMP sponge) combined with siRNA and multiple GTPase activation assays providing direct evidence for each cascade step","pmids":["26704387"],"is_preprint":false},{"year":2015,"finding":"Spinal 5-HT7 receptor-induced phrenic motor facilitation is mediated by EPAC and downstream mTORC1 in a PKA-independent manner; selective EPAC inhibitor (ESI-05) abolishes 5-HT7-induced facilitation while PKA inhibitor does not; direct EPAC activation (8-pCPT) is sufficient for facilitation.","method":"Intrathecal drug administration in anesthetized rats, selective EPAC inhibitor (ESI-05), PKA inhibitor (KT-5720), selective EPAC activator, mTORC1 inhibitor (rapamycin), phrenic nerve electrophysiology","journal":"Journal of neurophysiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological epistasis in vivo, single lab","pmids":["26269554"],"is_preprint":false},{"year":2015,"finding":"EPAC1 (RAPGEF3) regulates neuronal polarity and axon specification through Rap1b activation; EPAC1 knockout neurons show axon elongation and polarization defects; EPAC pharmacological activation induces supernumerary axons with mature axon markers.","method":"Epac-selective analogue (8-pCPT), shRNA knockdown of EPAC1, EPAC1 knockout mice neurons, Rap1b activation assay, immunostaining of axon markers (ankyrin G, synaptophysin, vGLUT1)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — pharmacological + shRNA + genetic KO mouse with multiple orthogonal markers","pmids":["26269639"],"is_preprint":false},{"year":2016,"finding":"EPAC-dependent vasorelaxation in mesenteric arteries occurs via Kv7 channel activation by Rap1a/Rap2 (downstream of EPAC), demonstrated by proximity ligation assay showing Kv7.4 co-localizes with Rap1a/Rap2 after EPAC stimulation; isoproterenol relaxation in mesenteric but not renal arteries is EPAC-dependent.","method":"Isometric tension recording, Kv7 inhibitor (linopirdine), EPAC inhibitor, PKA inhibitor, proximity ligation assay (Kv7.4 + Rap1a/Rap2 + AKAP), isolated mesenteric vs. renal arteries","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — proximity ligation assay plus pharmacological epistasis, single lab","pmids":["27789473"],"is_preprint":false},{"year":2017,"finding":"KLF2 transcriptionally controls RAPGEF3 (EPAC1) expression, maintaining endothelial barrier via Rac1 activation; KLF2 knockdown reduces RAPGEF3-Rac1 signaling and increases endothelial permeability; KLF2 overexpression ameliorates LPS-induced lung injury in mice.","method":"ChIP assay, luciferase reporter assay, siRNA knockdown, small GTPase activity assay, permeability measurements, KLF2 overexpression in mice, lung injury model","journal":"American journal of respiratory and critical care medicine","confidence":"High","confidence_rationale":"Tier 2 — ChIP confirms direct transcriptional regulation, multiple in vitro assays, and in vivo mouse model validation","pmids":["27855271"],"is_preprint":false},{"year":2017,"finding":"β-AR-induced SR Ca2+ leak in cardiomyocytes proceeds via a single series pathway: β-AR-cAMP-Epac-PI3K-Akt-NOS1-CaMKII; Epac activation (8-CPT) mimics β-AR-induced SR Ca2+ leak, blocked by NOS inhibition; PI3K and Akt are implicated between Epac and NOS1.","method":"Ca2+ spark frequency measurement, tetracaine-induced SR Ca2+ load assay, FRET-based CaMKII activity reporter, ryanodine receptor phosphorylation, pharmacological inhibitors for NOS/PI3K/Akt, Epac-selective agonist","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical and imaging approaches in mouse and rabbit cardiomyocytes establishing series pathway","pmids":["28476660"],"is_preprint":false},{"year":2017,"finding":"EPAC-Rap1 signaling prevents and reverses VEGF- and TNF-α-induced retinal vascular permeability; Rap1B knockdown or EPAC antagonist increases endothelial permeability; GTP-bound Rap1 promotes tight junction assembly; EPAC activation inhibits VEGFR signaling through Ras/MEK/ERK.","method":"Epac-selective agonist and antagonist, Rap1B siRNA knockdown, in vitro permeability assay, in vivo retinal permeability, tight junction immunofluorescence, VEGFR/ERK signaling assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic knockdown + pharmacological + in vivo with multiple functional readouts","pmids":["29158262"],"is_preprint":false},{"year":2017,"finding":"LPS-induced IL-33 production in macrophages requires endogenous PGE2 and EP2 receptors acting through cAMP/EPAC (not PKA); EPAC-selective agonist mimics PGE2 amplification of IL-33, and EPAC knockdown attenuates it.","method":"EPAC-selective agonist and antagonist, EPAC knockdown, mPGES-1 and EP2 knockout macrophages, IL-33 ELISA, in vivo Alternaria lung inflammation model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic knockouts combined with pharmacological EPAC tools and in vivo validation","pmids":["28341741"],"is_preprint":false},{"year":2021,"finding":"Exendin-4 stimulates autophagy in pancreatic β-cells via RAPGEF4/EPAC2-Ca2+-PPP3/calcineurin-TFEB axis; this pathway is independent of AMPK and mTOR; inhibition of this cascade prevents exendin-4-mediated cell survival; overexpression of TFEB mimics exendin-4 protective effects.","method":"Chemical inhibitors and siRNA knockdown of RAPGEF4/EPAC2, calcineurin inhibitors, TFEB overexpression, autophagic flux assays, caspase-3 activity, INS-1E cells and human islets","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown + pharmacological + overexpression in multiple cell systems, single lab","pmids":["34338148"],"is_preprint":false},{"year":2014,"finding":"Allosteric inhibitor compound 5376753 (thiobarbituric acid derivative) binds the hinge region of the cAMP-binding domain of Epac1 and selectively inhibits Epac activity and cell migration without affecting PKA.","method":"Computational molecular modeling, BRET-based CAMYEL assay, Rap1 activity assay, vasodilator-stimulated phosphoprotein phosphorylation (PKA readout), cell migration assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1/3 — computational prediction followed by biochemical validation, single lab","pmids":["25183009"],"is_preprint":false}],"current_model":"RAPGEF3 (EPAC1) is a multi-domain cAMP sensor that, upon cAMP binding, undergoes a hinge-mediated conformational change releasing autoinhibition to expose its catalytic domain, thereby activating the small GTPases Rap1 and Rap2 (and directly R-Ras) in a PKA-independent manner; activated Rap1 engages downstream effectors including PLCε, integrins, tight junction proteins, and ion channels (KATP, BKCa, Kv7) to regulate diverse cellular processes including vascular barrier function, cardiomyocyte hypertrophy and Ca2+ handling, insulin secretion, axon specification, cell adhesion and migration, and exocytosis, often through scaffolded signaling complexes involving AKAPs, PP2A, CaMKII, and PI3K/Akt/NOS pathways."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing that cAMP activates Rap1 through a PKA-independent GEF resolved whether all cAMP signaling funneled through PKA, revealing EPAC1 as a parallel cAMP effector.","evidence":"Selective cAMP analogue (8CPT-2Me-cAMP) activated Epac-dependent Rap1 but not PKA-dependent ERK in multiple cell lines","pmids":["12402047"],"confidence":"High","gaps":["Structural basis of cAMP selectivity between Epac and PKA not yet resolved","Endogenous physiological contexts not yet defined"]},{"year":2003,"claim":"Defining the autoinhibitory lid mechanism explained how cAMP binding allosterically activates Epac's catalytic domain, establishing the molecular switch that governs GEF activation.","evidence":"Mutagenesis of the cAMP-binding domain lid coupled with in vitro GEF assays and cAMP analogue titration","pmids":["12888551","19553663"],"confidence":"High","gaps":["Full-length crystal structure of active Epac1 not determined at that time","Role of the DEP and REM domains in autoinhibition not fully dissected"]},{"year":2004,"claim":"Discovery that EPAC1 acts as a direct GEF for R-Ras and signals through Rap2B/PLCε/Ca²⁺ to H-Ras/ERK expanded the substrate repertoire beyond Rap1 and connected EPAC to phospholipase and calcium signaling.","evidence":"In vitro GEF reconstitution with R-Ras, dominant-negative Rap2B/RapGAPII blocking ERK activation, PLD stimulation assays","pmids":["16754664","15319437"],"confidence":"High","gaps":["Whether R-Ras is a physiologically relevant substrate in all tissues remains unresolved","Relative contribution of Rap1 vs. Rap2B vs. R-Ras pathways in different cell types unclear"]},{"year":2005,"claim":"Placing Epac upstream of calcineurin/NFAT in cardiomyocyte hypertrophy and upstream of PKCε in nociceptor sensitization demonstrated that EPAC1 drives cell-type-specific Ca²⁺-dependent signaling outputs with physiological and pathological relevance.","evidence":"Epac-selective agonist in neonatal cardiomyocytes with calcineurin/Rac inhibitors; Epac agonist plus PLC/PLD/PKCε inhibitors in DRG neurons with behavioral pain readout","pmids":["16269655","15987941"],"confidence":"High","gaps":["Whether Epac1 vs Epac2 isoforms contribute differentially to cardiac hypertrophy not yet resolved","Endogenous GPCR identity activating Epac in cardiomyocytes not fully defined"]},{"year":2006,"claim":"Identification of Epac1/SUR1 complexes at KATP channels and Epac-triggered Ca²⁺ mobilization from ryanodine-sensitive stores established EPAC1 as a direct regulator of ion channel function and intracellular Ca²⁺ release.","evidence":"Co-IP of Epac with SUR1, patch-clamp showing Epac-dependent KATP inhibition blocked by dominant-negative Epac1; confocal Ca²⁺ imaging in IMCD with ryanodine receptor blockers","pmids":["16613879","16684923"],"confidence":"High","gaps":["Stoichiometry and structural basis of Epac-SUR1 interaction not defined","Whether Epac directly modulates ryanodine receptors or acts via intermediaries unclear"]},{"year":2008,"claim":"Discovery that Epac scaffolds with Akt/PP2A and with AKAP150/PKA/Akt revealed that EPAC1 operates within multiprotein signaling complexes enabling compartmentalized and bidirectional regulation of Akt phosphorylation.","evidence":"Co-IP of Epac-Akt-PP2A with functional phosphatase assay; co-IP of AKAP150-Epac-PKA-Akt in neurons with AKAP-disrupting peptides and siRNA","pmids":["18550542","18565730"],"confidence":"High","gaps":["Whether Epac1 vs Epac2 occupy the same or distinct AKAP complexes unclear","Post-translational modifications regulating scaffold assembly not characterized"]},{"year":2008,"claim":"Linking Epac to CaMKII-dependent arrhythmogenesis and β-AR-induced hypertrophic gene program via Ras/calcineurin/CaMKII cemented a pro-pathological cardiac signaling axis downstream of cAMP that is distinct from PKA.","evidence":"Epac-selective agonist in Langendorff-perfused hearts with CaMKII inhibitor; Epac1 siRNA in adult cardiomyocytes with Ras/calcineurin/CaMKII inhibitors","pmids":["18600344","18323524","20576488"],"confidence":"High","gaps":["Whether chronic Epac inhibition is cardioprotective in heart failure models not tested at this stage","Relative contribution of CaMKII vs calcineurin arm not quantified"]},{"year":2009,"claim":"Demonstration that EPAC1 controls endothelial angiogenesis via PI3K/Akt/eNOS, vascular relaxation via BKCa and endothelial SKCa/IKCa/NOS, and integrin-dependent progenitor cell homing established EPAC1 as a central regulator of vascular function.","evidence":"Epac1 siRNA suppressing Akt/eNOS with in vivo neovascularization; tension recording and Ca²⁺ spark imaging in mesenteric arteries; integrin affinity assays and hind limb ischemia model for progenitor homing","pmids":["19385062","23959673","18032709"],"confidence":"High","gaps":["Whether Epac1 is the dominant isoform in all vascular beds not established","Structural basis for Epac-PI3K coupling unknown"]},{"year":2009,"claim":"Defining the cAMP/Epac/Rap1/PLCε/IP3 cascade for acrosomal Ca²⁺ release during sperm exocytosis showed EPAC1 as the cAMP sensor for fertilization-relevant exocytosis, with Rab3A activated indirectly downstream.","evidence":"In vitro GEF assay showing no direct Epac activity on Rab3A; PLCε siRNA and Rap1-GTP pulldown in human sperm; TAT-cAMP sponge approach","pmids":["19546222","26704387"],"confidence":"High","gaps":["Whether Epac1 or Epac2 is the dominant isoform in human sperm exocytosis not definitively resolved","Direct visualization of Epac-Rap1-PLCε signalosome in sperm not achieved"]},{"year":2012,"claim":"Development of selective Epac inhibitors (ESI-09, CE3F4) with defined mechanisms of action provided critical pharmacological tools and confirmed that cellular phenotypes attributed to Epac (migration, Rap1 activation, insulin secretion) are on-target.","evidence":"CE3F4 uncompetitive kinetics in cell-free GEF assay; ESI-09 blocking Rap1 activation and Akt phosphorylation with functional readouts in cancer and β-cells","pmids":["23139415","23066090","25183009"],"confidence":"High","gaps":["Off-target effects of ESI-09 at higher concentrations debated","In vivo pharmacokinetics and selectivity of these inhibitors not fully characterized"]},{"year":2015,"claim":"EPAC1 knockout neurons displaying axon specification defects, rescued by pharmacological activation, established a non-redundant role for EPAC1-Rap1b in neuronal polarity, extending its function beyond growth cone guidance to fundamental cell fate decisions.","evidence":"EPAC1 KO mouse neurons, shRNA knockdown, Epac-selective agonist inducing supernumerary axons with mature markers (ankyrin G, synaptophysin, vGLUT1)","pmids":["26269639"],"confidence":"High","gaps":["Whether EPAC2 compensates partially in EPAC1 KO neurons not tested","Downstream effectors linking Rap1b to polarity determinants (Par complex, etc.) not identified"]},{"year":2017,"claim":"Mapping the complete β-AR-cAMP-Epac-PI3K-Akt-NOS1-CaMKII series pathway for SR Ca²⁺ leak, alongside Epac-Rap1 control of tight junctions and retinal vascular permeability, unified cardiac and vascular pathophysiology under EPAC1 signaling.","evidence":"Ca²⁺ spark frequency and FRET-CaMKII reporter with sequential pharmacological inhibitors in cardiomyocytes; Rap1B siRNA and Epac agonist/antagonist with in vivo retinal permeability","pmids":["28476660","29158262","27855271"],"confidence":"High","gaps":["Whether NOS1 vs NOS3 selectivity is cell-type dependent unclear","Structural basis for Epac-PI3K coupling in cardiomyocytes not defined"]},{"year":2017,"claim":"EPAC1 was placed downstream of PGE2/EP2 receptors in macrophage IL-33 production, revealing an innate immune signaling function and expanding EPAC's role to inflammatory cytokine regulation.","evidence":"EP2 and mPGES-1 KO macrophages, EPAC knockdown, EPAC-selective agonist, in vivo Alternaria lung inflammation model","pmids":["28341741"],"confidence":"High","gaps":["Whether EPAC1 regulates other alarmin cytokines besides IL-33 not investigated","Downstream Rap1 effectors mediating IL-33 transcription not identified"]},{"year":null,"claim":"Key unresolved questions include the isoform-specific contributions of EPAC1 vs EPAC2 across tissues, the structural basis of EPAC1 scaffolding with AKAP/PP2A/PI3K complexes, and whether chronic pharmacological EPAC1 inhibition is therapeutically viable in cardiac or vascular disease.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length active EPAC1 in complex with Rap1 and scaffold partners","Therapeutic window for EPAC1 inhibition in vivo not established","Isoform-specific knockout phenotype comparison across cardiovascular, neuronal, and immune systems incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,4,16,27,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,12,28,33,36]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,4,12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,24,33]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4,12,13,29,35]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[10,34,36]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[8,25,30]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[37]}],"complexes":["Epac1-Akt-PP2A complex","AKAP150-Epac-PKA-Akt complex","Epac-SUR1 complex"],"partners":["RAP1A","RAP1B","RRAS","ABCC8","AKT1","PPP2CA","AKAP5","MAP1A"],"other_free_text":[]},"mechanistic_narrative":"RAPGEF3 (EPAC1) is a cAMP-activated guanine nucleotide exchange factor that transduces cAMP signals independently of PKA, primarily by catalyzing GDP/GTP exchange on Rap1 and, to a lesser extent, on R-Ras [PMID:12402047, PMID:16754664]. cAMP binding releases an autoinhibitory interaction between the C-terminal helical lid of the cAMP-binding domain and the catalytic region, triggering a hinge-motion conformational change that exposes GEF activity [PMID:12888551, PMID:19553663]. Activated Rap1 engages downstream effectors—including PLCε, integrins, tight junction proteins, ion channels (KATP, BKCa, Kv7), and the PI3K/Akt/NOS/CaMKII axis—to regulate vascular barrier integrity, cardiomyocyte hypertrophy and Ca²⁺ handling, insulin secretion, exocytosis, neurite outgrowth, axon specification, and cell migration [PMID:16269655, PMID:28476660, PMID:26269639, PMID:29158262, PMID:18032709]. EPAC1 operates within scaffolded signaling complexes involving AKAPs, PP2A, and SUR1, enabling compartmentalized regulation of Akt, KATP channels, and calcineurin/NFAT signaling in cell-type-specific contexts [PMID:18550542, PMID:18565730, PMID:16613879]."},"prefetch_data":{"uniprot":{"accession":"O95398","full_name":"Rap guanine nucleotide exchange factor 3","aliases":["Exchange factor directly activated by cAMP 1","Exchange protein directly activated by cAMP 1","EPAC 1","Rap1 guanine-nucleotide-exchange factor directly activated by cAMP","cAMP-regulated guanine nucleotide exchange factor I","cAMP-GEFI"],"length_aa":923,"mass_kda":103.8,"function":"Guanine nucleotide exchange factor (GEF) for RAP1A and RAP2A small GTPases that is activated by binding cAMP. Through simultaneous binding of PDE3B to RAPGEF3 and PIK3R6 is assembled in a signaling complex in which it activates the PI3K gamma complex and which is involved in angiogenesis. Plays a role in the modulation of the cAMP-induced dynamic control of endothelial barrier function through a pathway that is independent on Rho-mediated signaling. Required for the actin rearrangement at cell-cell junctions, such as stress fibers and junctional actin","subcellular_location":"Endomembrane system","url":"https://www.uniprot.org/uniprotkb/O95398/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAPGEF3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RAPGEF3","total_profiled":1310},"omim":[{"mim_id":"609527","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; RAPGEF5","url":"https://www.omim.org/entry/609527"},{"mim_id":"606057","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RAPGEF3","url":"https://www.omim.org/entry/606057"},{"mim_id":"604990","title":"SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 1; SLC9A3R1","url":"https://www.omim.org/entry/604990"},{"mim_id":"182307","title":"SOLUTE CARRIER FAMILY 9, MEMBER 3; SLC9A3","url":"https://www.omim.org/entry/182307"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Cytosol","reliability":"Uncertain"},{"location":"Endoplasmic reticulum","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAPGEF3"},"hgnc":{"alias_symbol":["cAMP-GEFI","EPAC","bcm910"],"prev_symbol":[]},"alphafold":{"accession":"O95398","domains":[{"cath_id":"1.10.10.10","chopping":"88-223","consensus_level":"high","plddt":86.6309,"start":88,"end":223},{"cath_id":"2.60.120.10","chopping":"231-348","consensus_level":"high","plddt":92.7325,"start":231,"end":348},{"cath_id":"1.20.870.10","chopping":"360-372_385-518","consensus_level":"high","plddt":83.7563,"start":360,"end":518},{"cath_id":"3.10.20.90","chopping":"560-648","consensus_level":"high","plddt":91.6273,"start":560,"end":648},{"cath_id":"1.10.840.10","chopping":"655-862_894-919","consensus_level":"high","plddt":89.8106,"start":655,"end":919}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95398","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95398-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95398-F1-predicted_aligned_error_v6.png","plddt_mean":77.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAPGEF3","jax_strain_url":"https://www.jax.org/strain/search?query=RAPGEF3"},"sequence":{"accession":"O95398","fasta_url":"https://rest.uniprot.org/uniprotkb/O95398.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95398/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95398"}},"corpus_meta":[{"pmid":"12402047","id":"PMC_12402047","title":"A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12402047","citation_count":613,"is_preprint":false},{"pmid":"17084085","id":"PMC_17084085","title":"Epac proteins: multi-purpose cAMP targets.","date":"2006","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17084085","citation_count":436,"is_preprint":false},{"pmid":"20055708","id":"PMC_20055708","title":"Epac: defining a new mechanism for cAMP action.","date":"2010","source":"Annual review of pharmacology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/20055708","citation_count":391,"is_preprint":false},{"pmid":"18604457","id":"PMC_18604457","title":"Epac and PKA: a tale of two intracellular cAMP receptors.","date":"2008","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/18604457","citation_count":305,"is_preprint":false},{"pmid":"16973695","id":"PMC_16973695","title":"Cell physiology of cAMP sensor Epac.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16973695","citation_count":216,"is_preprint":false},{"pmid":"23066090","id":"PMC_23066090","title":"A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion.","date":"2012","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23066090","citation_count":188,"is_preprint":false},{"pmid":"15987941","id":"PMC_15987941","title":"Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15987941","citation_count":187,"is_preprint":false},{"pmid":"18323524","id":"PMC_18323524","title":"Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy.","date":"2008","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18323524","citation_count":178,"is_preprint":false},{"pmid":"29537337","id":"PMC_29537337","title":"Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.","date":"2018","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/29537337","citation_count":176,"is_preprint":false},{"pmid":"24316969","id":"PMC_24316969","title":"Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24316969","citation_count":164,"is_preprint":false},{"pmid":"16269655","id":"PMC_16269655","title":"cAMP-binding protein Epac induces cardiomyocyte hypertrophy.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16269655","citation_count":161,"is_preprint":false},{"pmid":"26941424","id":"PMC_26941424","title":"Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease.","date":"2016","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/26941424","citation_count":143,"is_preprint":false},{"pmid":"17716863","id":"PMC_17716863","title":"Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors.","date":"2007","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/17716863","citation_count":135,"is_preprint":false},{"pmid":"12888551","id":"PMC_12888551","title":"Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12888551","citation_count":135,"is_preprint":false},{"pmid":"18434542","id":"PMC_18434542","title":"The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18434542","citation_count":134,"is_preprint":false},{"pmid":"19912228","id":"PMC_19912228","title":"The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function.","date":"2009","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19912228","citation_count":127,"is_preprint":false},{"pmid":"16613879","id":"PMC_16613879","title":"cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16613879","citation_count":118,"is_preprint":false},{"pmid":"19210747","id":"PMC_19210747","title":"EPAC proteins transduce diverse cellular actions of cAMP.","date":"2009","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19210747","citation_count":117,"is_preprint":false},{"pmid":"21220320","id":"PMC_21220320","title":"Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21220320","citation_count":113,"is_preprint":false},{"pmid":"35805104","id":"PMC_35805104","title":"cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35805104","citation_count":107,"is_preprint":false},{"pmid":"18583150","id":"PMC_18583150","title":"Epac mediates cyclic AMP-dependent axon growth, guidance and regeneration.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18583150","citation_count":105,"is_preprint":false},{"pmid":"19385062","id":"PMC_19385062","title":"Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19385062","citation_count":104,"is_preprint":false},{"pmid":"38233872","id":"PMC_38233872","title":"cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.","date":"2024","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38233872","citation_count":100,"is_preprint":false},{"pmid":"21402149","id":"PMC_21402149","title":"Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/21402149","citation_count":100,"is_preprint":false},{"pmid":"15319437","id":"PMC_15319437","title":"Epac- and Ca2+ -controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15319437","citation_count":94,"is_preprint":false},{"pmid":"25791905","id":"PMC_25791905","title":"Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 \"therapeutic window\".","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25791905","citation_count":93,"is_preprint":false},{"pmid":"23139415","id":"PMC_23139415","title":"Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23139415","citation_count":89,"is_preprint":false},{"pmid":"20971121","id":"PMC_20971121","title":"PKA and Epac synergistically inhibit smooth muscle cell proliferation.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20971121","citation_count":86,"is_preprint":false},{"pmid":"19546222","id":"PMC_19546222","title":"Epac activates the small G proteins Rap1 and Rab3A to achieve exocytosis.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19546222","citation_count":83,"is_preprint":false},{"pmid":"31254940","id":"PMC_31254940","title":"EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.","date":"2019","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/31254940","citation_count":77,"is_preprint":false},{"pmid":"24149987","id":"PMC_24149987","title":"Epac-inhibitors: facts and artefacts.","date":"2013","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24149987","citation_count":76,"is_preprint":false},{"pmid":"25744542","id":"PMC_25744542","title":"The future of EPAC-targeted therapies: agonism versus antagonism.","date":"2015","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25744542","citation_count":76,"is_preprint":false},{"pmid":"18032709","id":"PMC_18032709","title":"Activation of Epac stimulates integrin-dependent homing of progenitor cells.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18032709","citation_count":72,"is_preprint":false},{"pmid":"19666481","id":"PMC_19666481","title":"The cAMP binding protein Epac regulates cardiac myofilament function.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19666481","citation_count":71,"is_preprint":false},{"pmid":"16684923","id":"PMC_16684923","title":"Epac-mediated Ca(2+) mobilization and exocytosis in inner medullary collecting duct.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16684923","citation_count":71,"is_preprint":false},{"pmid":"24733293","id":"PMC_24733293","title":"Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24733293","citation_count":71,"is_preprint":false},{"pmid":"18565730","id":"PMC_18565730","title":"Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18565730","citation_count":68,"is_preprint":false},{"pmid":"20516079","id":"PMC_20516079","title":"Differential roles of Epac in regulating cell death in neuronal and myocardial cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20516079","citation_count":68,"is_preprint":false},{"pmid":"18600344","id":"PMC_18600344","title":"Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.","date":"2008","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18600344","citation_count":66,"is_preprint":false},{"pmid":"16754664","id":"PMC_16754664","title":"Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16754664","citation_count":64,"is_preprint":false},{"pmid":"22363678","id":"PMC_22363678","title":"Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22363678","citation_count":61,"is_preprint":false},{"pmid":"25719403","id":"PMC_25719403","title":"Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes.","date":"2015","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/25719403","citation_count":60,"is_preprint":false},{"pmid":"32547400","id":"PMC_32547400","title":"Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32547400","citation_count":60,"is_preprint":false},{"pmid":"23535586","id":"PMC_23535586","title":"Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23535586","citation_count":60,"is_preprint":false},{"pmid":"24231725","id":"PMC_24231725","title":"Cyclic AMP sensor EPAC proteins and energy homeostasis.","date":"2013","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/24231725","citation_count":59,"is_preprint":false},{"pmid":"24824430","id":"PMC_24824430","title":"Involvement of cAMP/EPAC/TRPM2 activation in glucose- and incretin-induced insulin secretion.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24824430","citation_count":59,"is_preprint":false},{"pmid":"29158262","id":"PMC_29158262","title":"The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29158262","citation_count":58,"is_preprint":false},{"pmid":"28476660","id":"PMC_28476660","title":"β-Adrenergic induced SR Ca2+ leak is mediated by an Epac-NOS pathway.","date":"2017","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28476660","citation_count":57,"is_preprint":false},{"pmid":"20576488","id":"PMC_20576488","title":"Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway.","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20576488","citation_count":55,"is_preprint":false},{"pmid":"29216750","id":"PMC_29216750","title":"PDE/cAMP/Epac/C/EBP-β Signaling Cascade Regulates Mitochondria Biogenesis of Tubular Epithelial Cells in Renal Fibrosis.","date":"2018","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/29216750","citation_count":53,"is_preprint":false},{"pmid":"17491018","id":"PMC_17491018","title":"Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17491018","citation_count":52,"is_preprint":false},{"pmid":"27855271","id":"PMC_27855271","title":"Experimental Lung Injury Reduces Krüppel-like Factor 2 to Increase Endothelial Permeability via Regulation of RAPGEF3-Rac1 Signaling.","date":"2017","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27855271","citation_count":52,"is_preprint":false},{"pmid":"19920825","id":"PMC_19920825","title":"Epac inhibits migration and proliferation of human prostate carcinoma cells.","date":"2009","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19920825","citation_count":51,"is_preprint":false},{"pmid":"26119090","id":"PMC_26119090","title":"Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeutics.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26119090","citation_count":50,"is_preprint":false},{"pmid":"16754837","id":"PMC_16754837","title":"Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims.","date":"2006","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16754837","citation_count":50,"is_preprint":false},{"pmid":"18550542","id":"PMC_18550542","title":"A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18550542","citation_count":48,"is_preprint":false},{"pmid":"31787905","id":"PMC_31787905","title":"Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation.","date":"2019","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31787905","citation_count":47,"is_preprint":false},{"pmid":"19804812","id":"PMC_19804812","title":"Involvement of cAMP/Epac/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle.","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19804812","citation_count":46,"is_preprint":false},{"pmid":"27549789","id":"PMC_27549789","title":"The role of Epac in the heart.","date":"2016","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/27549789","citation_count":45,"is_preprint":false},{"pmid":"26269554","id":"PMC_26269554","title":"Spinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling.","date":"2015","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/26269554","citation_count":44,"is_preprint":false},{"pmid":"27789473","id":"PMC_27789473","title":"Kv7 Channel Activation Underpins EPAC-Dependent Relaxations of Rat Arteries.","date":"2016","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27789473","citation_count":42,"is_preprint":false},{"pmid":"23089371","id":"PMC_23089371","title":"Distinct PKA and Epac compartmentalization in airway function and plasticity.","date":"2012","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23089371","citation_count":41,"is_preprint":false},{"pmid":"30016400","id":"PMC_30016400","title":"Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling.","date":"2019","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/30016400","citation_count":41,"is_preprint":false},{"pmid":"19657062","id":"PMC_19657062","title":"Epac increases melanoma cell migration by a heparan sulfate-related mechanism.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19657062","citation_count":41,"is_preprint":false},{"pmid":"21493776","id":"PMC_21493776","title":"Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure.","date":"2011","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/21493776","citation_count":41,"is_preprint":false},{"pmid":"23959673","id":"PMC_23959673","title":"Exchange protein activated by cAMP (Epac) induces vascular relaxation by activating Ca2+-sensitive K+ channels in rat mesenteric artery.","date":"2013","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23959673","citation_count":41,"is_preprint":false},{"pmid":"26219954","id":"PMC_26219954","title":"Proarrhythmic effect of sustained EPAC activation on TRPC3/4 in rat ventricular cardiomyocytes.","date":"2015","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26219954","citation_count":39,"is_preprint":false},{"pmid":"24469067","id":"PMC_24469067","title":"PKA and Epac activation mediates cAMP-induced vasorelaxation by increasing endothelial NO production.","date":"2014","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24469067","citation_count":38,"is_preprint":false},{"pmid":"28341741","id":"PMC_28341741","title":"Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28341741","citation_count":38,"is_preprint":false},{"pmid":"29569077","id":"PMC_29569077","title":"Protective Effect of Quercetin in LPS-Induced Murine Acute Lung Injury Mediated by cAMP-Epac Pathway.","date":"2018","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/29569077","citation_count":38,"is_preprint":false},{"pmid":"24007532","id":"PMC_24007532","title":"Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24007532","citation_count":38,"is_preprint":false},{"pmid":"26704387","id":"PMC_26704387","title":"The signaling module cAMP/Epac/Rap1/PLCε/IP3 mobilizes acrosomal calcium during sperm exocytosis.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26704387","citation_count":37,"is_preprint":false},{"pmid":"30251651","id":"PMC_30251651","title":"Phoenixin-14 stimulates differentiation of 3T3-L1 preadipocytes via cAMP/Epac-dependent mechanism.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30251651","citation_count":37,"is_preprint":false},{"pmid":"26963850","id":"PMC_26963850","title":"Epac-protein kinase C alpha signaling in purinergic P2X3R-mediated hyperalgesia after inflammation.","date":"2016","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/26963850","citation_count":35,"is_preprint":false},{"pmid":"31722989","id":"PMC_31722989","title":"Adenosine Receptor Signaling Targets Both PKA and Epac Pathways to Polarize Dendritic Cells to a Suppressive Phenotype.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31722989","citation_count":35,"is_preprint":false},{"pmid":"20729327","id":"PMC_20729327","title":"Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20729327","citation_count":35,"is_preprint":false},{"pmid":"24256330","id":"PMC_24256330","title":"Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).","date":"2013","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24256330","citation_count":35,"is_preprint":false},{"pmid":"22511766","id":"PMC_22511766","title":"The Epac-Rap1 signaling pathway controls cAMP-mediated exocytosis of Weibel-Palade bodies in endothelial cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22511766","citation_count":35,"is_preprint":false},{"pmid":"22192627","id":"PMC_22192627","title":"Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22192627","citation_count":35,"is_preprint":false},{"pmid":"19553663","id":"PMC_19553663","title":"Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19553663","citation_count":35,"is_preprint":false},{"pmid":"20851749","id":"PMC_20851749","title":"New perspectives in cyclic AMP-mediated axon growth and guidance: The emerging epoch of Epac.","date":"2010","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/20851749","citation_count":34,"is_preprint":false},{"pmid":"20663796","id":"PMC_20663796","title":"Possible role of the exchange protein directly activated by cyclic AMP (Epac) in the cyclic AMP-dependent functional differentiation and syncytialization of human placental BeWo cells.","date":"2010","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20663796","citation_count":34,"is_preprint":false},{"pmid":"30807826","id":"PMC_30807826","title":"Methylglyoxal and a spinal TRPA1-AC1-Epac cascade facilitate pain in the db/db mouse model of type 2 diabetes.","date":"2019","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30807826","citation_count":33,"is_preprint":false},{"pmid":"32899451","id":"PMC_32899451","title":"The Role of Epac in Cancer Progression.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32899451","citation_count":32,"is_preprint":false},{"pmid":"34338148","id":"PMC_34338148","title":"Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34338148","citation_count":32,"is_preprint":false},{"pmid":"23307791","id":"PMC_23307791","title":"Glucagon stimulates ghrelin secretion through the activation of MAPK and EPAC and potentiates the effect of norepinephrine.","date":"2013","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23307791","citation_count":32,"is_preprint":false},{"pmid":"33298248","id":"PMC_33298248","title":"Epac: new emerging cAMP-binding protein.","date":"2021","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/33298248","citation_count":31,"is_preprint":false},{"pmid":"21471298","id":"PMC_21471298","title":"Guanine-nucleotide exchange factors (RAPGEF3/RAPGEF4) induce sperm membrane depolarization and acrosomal exocytosis in capacitated stallion sperm.","date":"2011","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/21471298","citation_count":31,"is_preprint":false},{"pmid":"29417338","id":"PMC_29417338","title":"Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment.","date":"2018","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29417338","citation_count":31,"is_preprint":false},{"pmid":"15202935","id":"PMC_15202935","title":"Exchange protein directly activated by cAMP (EPAC) interacts with the light chain (LC) 2 of MAP1A.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15202935","citation_count":30,"is_preprint":false},{"pmid":"31593773","id":"PMC_31593773","title":"Laminin-driven Epac/Rap1 regulation of epithelial barriers on decellularized matrix.","date":"2019","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/31593773","citation_count":29,"is_preprint":false},{"pmid":"29401660","id":"PMC_29401660","title":"Epac Function and cAMP Scaffolds in the Heart and Lung.","date":"2018","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/29401660","citation_count":28,"is_preprint":false},{"pmid":"24467222","id":"PMC_24467222","title":"Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.","date":"2014","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24467222","citation_count":28,"is_preprint":false},{"pmid":"25220136","id":"PMC_25220136","title":"Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling.","date":"2014","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25220136","citation_count":28,"is_preprint":false},{"pmid":"26269639","id":"PMC_26269639","title":"Exchange Protein Directly Activated by cAMP (EPAC) Regulates Neuronal Polarization through Rap1B.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26269639","citation_count":27,"is_preprint":false},{"pmid":"28632993","id":"PMC_28632993","title":"The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers.","date":"2017","source":"Tissue barriers","url":"https://pubmed.ncbi.nlm.nih.gov/28632993","citation_count":27,"is_preprint":false},{"pmid":"26854595","id":"PMC_26854595","title":"EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1.","date":"2015","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26854595","citation_count":27,"is_preprint":false},{"pmid":"36931001","id":"PMC_36931001","title":"Activation of the Epac/Rap1 signaling pathway alleviates blood-brain barrier disruption and brain damage following cerebral ischemia/reperfusion injury.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36931001","citation_count":27,"is_preprint":false},{"pmid":"24586073","id":"PMC_24586073","title":"Possible roles of the cAMP-mediators EPAC and RAP1 in decidualization of rat uterus.","date":"2014","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24586073","citation_count":26,"is_preprint":false},{"pmid":"25183009","id":"PMC_25183009","title":"Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25183009","citation_count":26,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52330,"output_tokens":9531,"usd":0.149978},"stage2":{"model":"claude-opus-4-6","input_tokens":13435,"output_tokens":3876,"usd":0.246113},"total_usd":0.396091,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"EPAC1 (RAPGEF3) functions as a cAMP-activated guanine nucleotide exchange factor (GEF) for Rap1; a selective cAMP analogue (8CPT-2Me-cAMP) activates Epac but not PKA, demonstrating that cAMP-induced Rap1 activation and ERK regulation are independent processes.\",\n      \"method\": \"Selective cAMP analogue pharmacology (8CPT-2Me-cAMP), in vitro and cell-based GEF assays, ERK activity measurements\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rational drug design with in vitro and in vivo validation, replicated across multiple cell lines\",\n      \"pmids\": [\"12402047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Epac activation requires cAMP binding that releases inhibitory interaction between the C-terminal helical lid of the cAMP-binding domain and the catalytic region; mutational analysis of the lid region modulates activation potency of cAMP analogues.\",\n      \"method\": \"Mutational analysis of Epac cAMP-binding domain lid region, in vitro GEF activity assays with cAMP analogues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-guided mutagenesis combined with in vitro enzymatic assays\",\n      \"pmids\": [\"12888551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"EPAC1 directly interacts with R-Ras and catalyzes GDP/GTP exchange on R-Ras in vitro; Epac-mediated R-Ras activation downstream of Gs-coupled receptors specifically controls phospholipase D stimulation.\",\n      \"method\": \"In vitro GEF assay (recombinant Epac1 + R-Ras), dominant-negative Epac1 mutant, siRNA depletion of Epac1, Rap GTPase-activating protein II expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro GEF reconstitution plus multiple genetic loss-of-function approaches\",\n      \"pmids\": [\"16754664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"EPAC1 interacts with the light chain 2 (LC2) of microtubule-associated protein 1A (MAP1A) via its cAMP-binding domain; this interaction was confirmed by two-hybrid, co-immunoprecipitation, and GST pull-down assays.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, GST pull-down assay, immunolocalization in HEK293 and COS1 cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — reciprocal co-IP and pull-down with domain mapping, single lab\",\n      \"pmids\": [\"15202935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Epac1 activates H-Ras and subsequently ERK1/2 via a pathway involving Rap2B and phospholipase C-epsilon (PLC-ε), leading to intracellular Ca2+ increase that activates a Ca2+-sensitive Ras-GEF (possibly RasGRP1); dominant-negative Rap2B and RapGAPII block this pathway.\",\n      \"method\": \"Dominant-negative mutants (H-Ras, Rap2B), Epac-selective cAMP analogue, constitutively active Rap2B, cAMP-binding-deficient Epac1 mutant, ERK1/2 activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic tools (dominant-negatives, constitutively active mutants, binding-deficient mutant) with functional readouts\",\n      \"pmids\": [\"15319437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In IB4+ DRG nociceptors, cAMP signals to PKCε via Epac (not PKA), with Epac acting upstream of phospholipase C and PLD, both required for PKCε translocation and activation; this pathway mediates cAMP-induced mechanical hyperalgesia.\",\n      \"method\": \"Selective Epac agonist, pharmacological inhibition of PLC/PLD/PKCε, behavioral pain model, cultured DRG neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with in vitro and in vivo behavioral validation\",\n      \"pmids\": [\"15987941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Epac activation in cardiomyocytes induces hypertrophy through Ca2+-dependent activation of Rac, calcineurin/NFAT pathway; Rac and calcineurin inhibition blunts the Epac-induced hypertrophic response.\",\n      \"method\": \"Epac-selective cAMP analogue, dominant-negative Rac, calcineurin inhibitor, NFAT reporter assay in neonatal cardiomyocytes\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal pharmacological and genetic inhibition approaches with defined phenotypic readout\",\n      \"pmids\": [\"16269655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Epac1 and Epac2 co-immunoprecipitate with full-length sulphonylurea receptor 1 (SUR1) in HEK cells; Epac-selective cAMP analogues inhibit ATP-sensitive K+ (KATP) channel function in human beta cells and INS-1 cells, an effect abolished by dominant-negative Epac1.\",\n      \"method\": \"Co-immunoprecipitation (Epac + SUR1), patch-clamp electrophysiology, dominant-negative Epac1 transfection, Epac-selective vs. PKA-selective cAMP analogues\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct protein interaction (Co-IP) combined with functional electrophysiology and dominant-negative validation\",\n      \"pmids\": [\"16613879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Epac activation triggers intracellular Ca2+ mobilization via ryanodine-sensitive stores and apical exocytotic insertion of aquaporin-2 (AQP2) in inner medullary collecting duct (IMCD), independent of PKA.\",\n      \"method\": \"Confocal fluorescence microscopy in perfused IMCD, Epac-selective cAMP agonist, ryanodine receptor blocker, PKA inhibitors, immunolocalization of AQP2\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live imaging with pharmacological pathway dissection, single lab\",\n      \"pmids\": [\"16684923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Anthrax edema toxin-generated cAMP inhibits endothelial cell chemotaxis via Epac and Rap1; activated Epac or Rap1 induces cytoskeletal changes and blocks chemotaxis; ET also induces transcription of Epac2 and MR-GEF/RapGEF5.\",\n      \"method\": \"cAMP analogue pharmacology, constitutively active Epac/Rap1 overexpression, chemotaxis assays, cytoskeletal imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with functional cellular readout, single lab\",\n      \"pmids\": [\"17491018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Pharmacological activation of Epac1 increases Rap1 activity, stimulates beta1- and beta2-integrin-dependent adhesion and migration of endothelial progenitor cells, rapidly increases lateral mobility and affinity of beta1-integrins, and enhances homing to ischemic muscle in vivo.\",\n      \"method\": \"Epac-selective cAMP analogue, Rap1 activity assay (pulldown), integrin affinity/avidity assays, hind limb ischemia mouse model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro assays plus in vivo validation\",\n      \"pmids\": [\"18032709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Epac1 mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy through Ras (not Rap1), calcineurin, and CaMKII in a PKA-independent manner; Epac1 knockdown reduces beta-AR-induced hypertrophic gene program.\",\n      \"method\": \"Epac-selective analogue, Epac1 siRNA knockdown, Ras/Rap1 activity assays, calcineurin and CaMKII inhibitors, adult ventricular myocytes\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + genetic (siRNA) + epistatic pathway dissection in primary cardiomyocytes\",\n      \"pmids\": [\"18323524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Epac forms a complex with Akt and PP2A; cAMP activates Epac-associated PP2A in a PKA- and Rap1-dependent manner, leading to Akt dephosphorylation; both Epac- and PKA-specific analogues synergistically regulate this Epac-Rap1b-PP2A module controlling Akt.\",\n      \"method\": \"Co-immunoprecipitation (Epac-Akt-PP2A complex), Epac-selective vs. PKA-selective cAMP analogues, dominant-negative Epac, dominant-negative PP2A, phosphatase activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein complex identification by Co-IP with functional phosphatase activity assay and multiple pathway perturbations\",\n      \"pmids\": [\"18550542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"AKAP150 forms complexes with PKA, PKB/Akt, and Epac in neurons; Epac activation increases PKB/Akt phosphorylation in a Rap-dependent manner, and this effect is mediated through AKAP150-anchored signaling; Epac2 siRNA preferentially blocks this Epac-mediated Akt phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation (AKAP150 with Epac/PKA/Akt), Epac-selective analogue, siRNA knockdown of Epac1/Epac2, PKA-anchoring-deficient AKAP150 mutant, AKAP-disrupting peptides\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus genetic (siRNA) and dominant-negative approach in primary neurons\",\n      \"pmids\": [\"18565730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Epac activation induces ventricular arrhythmias in intact murine hearts associated with altered intracellular Ca2+ homeostasis in ventricular myocytes; these effects are reduced by CaMKII inhibition, placing CaMKII downstream of Epac in cardiac Ca2+ dysregulation.\",\n      \"method\": \"Langendorff-perfused mouse heart, monophasic action potential recording, programmed electrical stimulation, fluorescence Ca2+ imaging, CaMKII inhibitor (KN-93), Epac-selective cAMP analogue\",\n      \"journal\": \"Pflugers Archiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular mechanism (CaMKII) with intact organ functional readout, single lab\",\n      \"pmids\": [\"18600344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Epac (RAPGEF3) promotes DRG neurite outgrowth and regeneration on spinal cord tissue in a cAMP-dependent, PKA-independent manner; siRNA knockdown of Epac reduces neurite outgrowth and prevents cAMP-elevation-induced growth; asymmetric Epac activation promotes attractive growth cone turning.\",\n      \"method\": \"Epac-selective cAMP analogue, siRNA knockdown, neurite outgrowth assays on spinal cord substrate, growth cone turning assay\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological activation plus genetic knockdown with defined neurite outgrowth and guidance readouts\",\n      \"pmids\": [\"18583150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac stimulates GDP/GTP exchange on Rap1 upstream of PLC, leading to IP3-dependent Ca2+ mobilization from acrosomal stores during sperm exocytosis; Epac also indirectly activates Rab3A (not via direct GEF activity) via a pathway downstream of soluble adenylyl cyclase/cAMP/Epac but not Rap1.\",\n      \"method\": \"Recombinant Epac in vitro GEF assay on Rab3A and Rap1, Epac-selective cAMP analogue, PLC inhibitors, Ca2+ mobilization measurements in human sperm\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution (recombinant Epac GEF assay) plus pharmacological pathway dissection\",\n      \"pmids\": [\"19546222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac activation reduces Ca2+ transient amplitude and increases myofilament Ca2+ sensitivity in cardiomyocytes; Epac increases phosphorylation of cardiac Troponin I and MyBP-C via PKC and CaMKII (not PKA), constituting a novel regulator of myofilament function.\",\n      \"method\": \"Epac-selective analogue, constitutively active Epac in vivo infection, permeabilized cardiomyocyte Ca2+ sensitivity assays, PKC/CaMKII inhibitors, sarcomeric protein phosphorylation analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + genetic (constitutively active Epac) + biochemical phosphorylation assays with defined functional readouts\",\n      \"pmids\": [\"19666481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac1 activates H-Ras in neonatal cardiac myocytes via a PLC/IP3R/Ca2+ cascade downstream of Rap; Epac1 activation induces HDAC4 nuclear export and, in the presence of HDAC4, HDAC5 also becomes responsive; CaMKII mediates MEF2 activation, linking Epac to pro-hypertrophic gene expression.\",\n      \"method\": \"RapGAP overexpression, PLC/IP3R inhibitors, constitutively active Epac1, HDAC4/5 translocation assays, CaMKII inhibitor, MEF2 reporter in cardiac myocytes\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway dissection with multiple inhibitors and genetic tools plus functional gene expression readouts\",\n      \"pmids\": [\"20576488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EPAC1 promotes angiogenesis in endothelial cells via Akt/eNOS/NO signaling and ERK phosphorylation in a PI3K-dependent, PKA-independent manner; siRNA knockdown of Epac1 suppresses Akt/eNOS phosphorylation and angiogenesis without affecting CREB phosphorylation or VEGF expression.\",\n      \"method\": \"Epac-selective cAMP analogue (8CPT-2Me-cAMP), Epac1 siRNA knockdown, phosphorylation assays, in vitro angiogenesis assay, in vivo neovascularization\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + genetic (siRNA) with multiple orthogonal functional readouts including in vivo\",\n      \"pmids\": [\"19385062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac1 mediates cAMP-induced inhibition of migration and proliferation in prostate carcinoma cells through inhibition of MAP kinase and RhoA signaling, while activating Rap1.\",\n      \"method\": \"Epac-selective cAMP analogue, Rap1/RhoA pulldown assays, MAP kinase immunoblotting, scratch migration assay, [3H]thymidine incorporation, phalloidin cytoskeleton staining\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological activation with multiple biochemical and functional readouts, single lab\",\n      \"pmids\": [\"19920825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac increases melanoma cell migration via syndecan-2 translocation to lipid rafts regulated by tubulin polymerization through the Epac/PI3K pathway, and via increased NDST-1 expression leading to enhanced heparan sulfate production.\",\n      \"method\": \"Epac-specific agonist, Epac overexpression, Epac siRNA, syndecan-2 localization assay, in vivo lung colonization model\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + genetic approaches with defined mechanistic molecular intermediates, single lab\",\n      \"pmids\": [\"19657062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Epac1 genetic disruption in mice abolishes 3-nitropropionic acid-induced neuronal apoptosis in vivo; Epac promotes cortical neuron-specific apoptosis by transcriptionally upregulating Bim expression, and Bim silencing attenuates Epac-induced neuronal apoptosis.\",\n      \"method\": \"Epac1 knockout mice, 3-NP in vivo model, Bim siRNA, TUNEL staining, DNA fragmentation assay, Bim mRNA quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO mouse with in vivo readout plus siRNA rescue in vitro\",\n      \"pmids\": [\"20516079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Taurocholate-induced hepatocyte polarization proceeds through a cAMP-Epac-MEK-Rap1-LKB1-AMPK pathway; inhibition of Epac downstream targets Rap1 and MEK blocks taurocholate-induced bile canalicular network formation.\",\n      \"method\": \"Pharmacological inhibitors of adenylyl cyclase, PKA, Epac, Rap1, MEK; kinase activation assays (MEK, LKB1, AMPK); rat hepatocyte sandwich cultures; bile canaliculi imaging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multi-step epistasis using specific inhibitors at each node of the pathway with defined morphological readout\",\n      \"pmids\": [\"21220320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RAPGEF3 is localized to the acrosome and subacrosomal ring in equine sperm; activation of RAPGEF3/RAPGEF4 induces acrosomal exocytosis in capacitated sperm and prevents hyperpolarization of the sperm plasma membrane, identifying a role for RAPGEF3 in membrane potential regulation during fertilization.\",\n      \"method\": \"Indirect immunofluorescence localization, RAPGEF3/4-selective cAMP analogue (8pCPT), acrosomal exocytosis assay, membrane potential measurements\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization plus functional pharmacology, single lab\",\n      \"pmids\": [\"21471298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The Epac-Rap1 signaling pathway controls cAMP-mediated Weibel-Palade body (WPB) exocytosis in endothelial cells; siRNA knockdown of Epac1 abolishes epinephrine-induced Rap1 activation and reduces WPB exocytosis; Rap1GAP overexpression or Rap1 siRNA also reduces epinephrine-induced exocytosis.\",\n      \"method\": \"siRNA knockdown of Epac1 and Rap1, Rap1GAP overexpression, WPB exocytosis assay, Rap1 activation pulldown, epinephrine stimulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic loss-of-function approaches with defined cellular functional readout\",\n      \"pmids\": [\"22511766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"EPAC1 plays an important role in pancreatic cancer cell migration and invasion; the EPAC-specific inhibitor ESI-09 blocks intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion.\",\n      \"method\": \"EPAC-specific inhibitor (ESI-09), Rap1 activation assay, Akt phosphorylation, migration and invasion assays, insulin secretion assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibitor with multiple biochemical readouts, single lab\",\n      \"pmids\": [\"23066090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CE3F4, a tetrahydroquinoline Epac1 inhibitor, blocks Epac1 GEF activity toward Rap1 in cell-free systems and intact cells without inhibiting PKA or directly affecting Rap1 GDP exchange; kinetic analysis indicates uncompetitive inhibition with respect to Epac1 agonists.\",\n      \"method\": \"Cell-free GEF assay, intact cell Rap1 activation assay, PKA holoenzyme activity assay, kinetics of inhibition, structure-activity relationship analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cell-free GEF reconstitution with mechanistic kinetic analysis and SAR\",\n      \"pmids\": [\"23139415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac activation induces vascular relaxation in rat mesenteric arteries through two mechanisms: (1) increasing ryanodine receptor-dependent Ca2+ sparks to activate BKCa channels in smooth muscle, and (2) endothelium-dependent SKCa/IKCa channel activation and NOS stimulation.\",\n      \"method\": \"Isometric tension recording, patch-clamp (STOCs), Ca2+ spark imaging (Fluo-4), iberiotoxin, apamin, TRAM-34, L-NAME, ryanodine, endothelium removal\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple electrophysiological and imaging approaches with pharmacological pathway dissection\",\n      \"pmids\": [\"23959673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Epac activation mediates hinge-motion-dependent conformational change in the enzyme: substitution of conserved phenylalanine 435 with glycine (F435G) in Epac2 yields constitutively active enzyme without cAMP, while F435W impedes hinge motion and dramatically reduces catalytic activity.\",\n      \"method\": \"Site-directed mutagenesis, in vitro GEF activity assay, small angle X-ray scattering (SAXS) for structural parameters\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with in vitro enzymatic assay and SAXS structural validation\",\n      \"pmids\": [\"19553663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Phospholipase Cε (PLCε) is required for the acrosome reaction downstream of Rap1 and upstream of intra-acrosomal Ca2+ mobilization; the cAMP/Epac/Rap1/PLCε/IP3 cascade constitutes the signaling module for acrosomal Ca2+ release during sperm exocytosis.\",\n      \"method\": \"TAT-cAMP sponge (sequester endogenous cAMP), siRNA for PLCε, Rap1-GTP pulldown, Ca2+ mobilization measurement, Rab3-GTP pulldown\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — novel molecular tool (TAT-cAMP sponge) combined with siRNA and multiple GTPase activation assays providing direct evidence for each cascade step\",\n      \"pmids\": [\"26704387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Spinal 5-HT7 receptor-induced phrenic motor facilitation is mediated by EPAC and downstream mTORC1 in a PKA-independent manner; selective EPAC inhibitor (ESI-05) abolishes 5-HT7-induced facilitation while PKA inhibitor does not; direct EPAC activation (8-pCPT) is sufficient for facilitation.\",\n      \"method\": \"Intrathecal drug administration in anesthetized rats, selective EPAC inhibitor (ESI-05), PKA inhibitor (KT-5720), selective EPAC activator, mTORC1 inhibitor (rapamycin), phrenic nerve electrophysiology\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis in vivo, single lab\",\n      \"pmids\": [\"26269554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EPAC1 (RAPGEF3) regulates neuronal polarity and axon specification through Rap1b activation; EPAC1 knockout neurons show axon elongation and polarization defects; EPAC pharmacological activation induces supernumerary axons with mature axon markers.\",\n      \"method\": \"Epac-selective analogue (8-pCPT), shRNA knockdown of EPAC1, EPAC1 knockout mice neurons, Rap1b activation assay, immunostaining of axon markers (ankyrin G, synaptophysin, vGLUT1)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + shRNA + genetic KO mouse with multiple orthogonal markers\",\n      \"pmids\": [\"26269639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EPAC-dependent vasorelaxation in mesenteric arteries occurs via Kv7 channel activation by Rap1a/Rap2 (downstream of EPAC), demonstrated by proximity ligation assay showing Kv7.4 co-localizes with Rap1a/Rap2 after EPAC stimulation; isoproterenol relaxation in mesenteric but not renal arteries is EPAC-dependent.\",\n      \"method\": \"Isometric tension recording, Kv7 inhibitor (linopirdine), EPAC inhibitor, PKA inhibitor, proximity ligation assay (Kv7.4 + Rap1a/Rap2 + AKAP), isolated mesenteric vs. renal arteries\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — proximity ligation assay plus pharmacological epistasis, single lab\",\n      \"pmids\": [\"27789473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KLF2 transcriptionally controls RAPGEF3 (EPAC1) expression, maintaining endothelial barrier via Rac1 activation; KLF2 knockdown reduces RAPGEF3-Rac1 signaling and increases endothelial permeability; KLF2 overexpression ameliorates LPS-induced lung injury in mice.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, siRNA knockdown, small GTPase activity assay, permeability measurements, KLF2 overexpression in mice, lung injury model\",\n      \"journal\": \"American journal of respiratory and critical care medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct transcriptional regulation, multiple in vitro assays, and in vivo mouse model validation\",\n      \"pmids\": [\"27855271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"β-AR-induced SR Ca2+ leak in cardiomyocytes proceeds via a single series pathway: β-AR-cAMP-Epac-PI3K-Akt-NOS1-CaMKII; Epac activation (8-CPT) mimics β-AR-induced SR Ca2+ leak, blocked by NOS inhibition; PI3K and Akt are implicated between Epac and NOS1.\",\n      \"method\": \"Ca2+ spark frequency measurement, tetracaine-induced SR Ca2+ load assay, FRET-based CaMKII activity reporter, ryanodine receptor phosphorylation, pharmacological inhibitors for NOS/PI3K/Akt, Epac-selective agonist\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical and imaging approaches in mouse and rabbit cardiomyocytes establishing series pathway\",\n      \"pmids\": [\"28476660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"EPAC-Rap1 signaling prevents and reverses VEGF- and TNF-α-induced retinal vascular permeability; Rap1B knockdown or EPAC antagonist increases endothelial permeability; GTP-bound Rap1 promotes tight junction assembly; EPAC activation inhibits VEGFR signaling through Ras/MEK/ERK.\",\n      \"method\": \"Epac-selective agonist and antagonist, Rap1B siRNA knockdown, in vitro permeability assay, in vivo retinal permeability, tight junction immunofluorescence, VEGFR/ERK signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockdown + pharmacological + in vivo with multiple functional readouts\",\n      \"pmids\": [\"29158262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LPS-induced IL-33 production in macrophages requires endogenous PGE2 and EP2 receptors acting through cAMP/EPAC (not PKA); EPAC-selective agonist mimics PGE2 amplification of IL-33, and EPAC knockdown attenuates it.\",\n      \"method\": \"EPAC-selective agonist and antagonist, EPAC knockdown, mPGES-1 and EP2 knockout macrophages, IL-33 ELISA, in vivo Alternaria lung inflammation model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockouts combined with pharmacological EPAC tools and in vivo validation\",\n      \"pmids\": [\"28341741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Exendin-4 stimulates autophagy in pancreatic β-cells via RAPGEF4/EPAC2-Ca2+-PPP3/calcineurin-TFEB axis; this pathway is independent of AMPK and mTOR; inhibition of this cascade prevents exendin-4-mediated cell survival; overexpression of TFEB mimics exendin-4 protective effects.\",\n      \"method\": \"Chemical inhibitors and siRNA knockdown of RAPGEF4/EPAC2, calcineurin inhibitors, TFEB overexpression, autophagic flux assays, caspase-3 activity, INS-1E cells and human islets\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown + pharmacological + overexpression in multiple cell systems, single lab\",\n      \"pmids\": [\"34338148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Allosteric inhibitor compound 5376753 (thiobarbituric acid derivative) binds the hinge region of the cAMP-binding domain of Epac1 and selectively inhibits Epac activity and cell migration without affecting PKA.\",\n      \"method\": \"Computational molecular modeling, BRET-based CAMYEL assay, Rap1 activity assay, vasodilator-stimulated phosphoprotein phosphorylation (PKA readout), cell migration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/3 — computational prediction followed by biochemical validation, single lab\",\n      \"pmids\": [\"25183009\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAPGEF3 (EPAC1) is a multi-domain cAMP sensor that, upon cAMP binding, undergoes a hinge-mediated conformational change releasing autoinhibition to expose its catalytic domain, thereby activating the small GTPases Rap1 and Rap2 (and directly R-Ras) in a PKA-independent manner; activated Rap1 engages downstream effectors including PLCε, integrins, tight junction proteins, and ion channels (KATP, BKCa, Kv7) to regulate diverse cellular processes including vascular barrier function, cardiomyocyte hypertrophy and Ca2+ handling, insulin secretion, axon specification, cell adhesion and migration, and exocytosis, often through scaffolded signaling complexes involving AKAPs, PP2A, CaMKII, and PI3K/Akt/NOS pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RAPGEF3 (EPAC1) is a cAMP-activated guanine nucleotide exchange factor that transduces cAMP signals independently of PKA, primarily by catalyzing GDP/GTP exchange on Rap1 and, to a lesser extent, on R-Ras [PMID:12402047, PMID:16754664]. cAMP binding releases an autoinhibitory interaction between the C-terminal helical lid of the cAMP-binding domain and the catalytic region, triggering a hinge-motion conformational change that exposes GEF activity [PMID:12888551, PMID:19553663]. Activated Rap1 engages downstream effectors—including PLCε, integrins, tight junction proteins, ion channels (KATP, BKCa, Kv7), and the PI3K/Akt/NOS/CaMKII axis—to regulate vascular barrier integrity, cardiomyocyte hypertrophy and Ca²⁺ handling, insulin secretion, exocytosis, neurite outgrowth, axon specification, and cell migration [PMID:16269655, PMID:28476660, PMID:26269639, PMID:29158262, PMID:18032709]. EPAC1 operates within scaffolded signaling complexes involving AKAPs, PP2A, and SUR1, enabling compartmentalized regulation of Akt, KATP channels, and calcineurin/NFAT signaling in cell-type-specific contexts [PMID:18550542, PMID:18565730, PMID:16613879].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that cAMP activates Rap1 through a PKA-independent GEF resolved whether all cAMP signaling funneled through PKA, revealing EPAC1 as a parallel cAMP effector.\",\n      \"evidence\": \"Selective cAMP analogue (8CPT-2Me-cAMP) activated Epac-dependent Rap1 but not PKA-dependent ERK in multiple cell lines\",\n      \"pmids\": [\"12402047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of cAMP selectivity between Epac and PKA not yet resolved\", \"Endogenous physiological contexts not yet defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defining the autoinhibitory lid mechanism explained how cAMP binding allosterically activates Epac's catalytic domain, establishing the molecular switch that governs GEF activation.\",\n      \"evidence\": \"Mutagenesis of the cAMP-binding domain lid coupled with in vitro GEF assays and cAMP analogue titration\",\n      \"pmids\": [\"12888551\", \"19553663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length crystal structure of active Epac1 not determined at that time\", \"Role of the DEP and REM domains in autoinhibition not fully dissected\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that EPAC1 acts as a direct GEF for R-Ras and signals through Rap2B/PLCε/Ca²⁺ to H-Ras/ERK expanded the substrate repertoire beyond Rap1 and connected EPAC to phospholipase and calcium signaling.\",\n      \"evidence\": \"In vitro GEF reconstitution with R-Ras, dominant-negative Rap2B/RapGAPII blocking ERK activation, PLD stimulation assays\",\n      \"pmids\": [\"16754664\", \"15319437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether R-Ras is a physiologically relevant substrate in all tissues remains unresolved\", \"Relative contribution of Rap1 vs. Rap2B vs. R-Ras pathways in different cell types unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Placing Epac upstream of calcineurin/NFAT in cardiomyocyte hypertrophy and upstream of PKCε in nociceptor sensitization demonstrated that EPAC1 drives cell-type-specific Ca²⁺-dependent signaling outputs with physiological and pathological relevance.\",\n      \"evidence\": \"Epac-selective agonist in neonatal cardiomyocytes with calcineurin/Rac inhibitors; Epac agonist plus PLC/PLD/PKCε inhibitors in DRG neurons with behavioral pain readout\",\n      \"pmids\": [\"16269655\", \"15987941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac1 vs Epac2 isoforms contribute differentially to cardiac hypertrophy not yet resolved\", \"Endogenous GPCR identity activating Epac in cardiomyocytes not fully defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of Epac1/SUR1 complexes at KATP channels and Epac-triggered Ca²⁺ mobilization from ryanodine-sensitive stores established EPAC1 as a direct regulator of ion channel function and intracellular Ca²⁺ release.\",\n      \"evidence\": \"Co-IP of Epac with SUR1, patch-clamp showing Epac-dependent KATP inhibition blocked by dominant-negative Epac1; confocal Ca²⁺ imaging in IMCD with ryanodine receptor blockers\",\n      \"pmids\": [\"16613879\", \"16684923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of Epac-SUR1 interaction not defined\", \"Whether Epac directly modulates ryanodine receptors or acts via intermediaries unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that Epac scaffolds with Akt/PP2A and with AKAP150/PKA/Akt revealed that EPAC1 operates within multiprotein signaling complexes enabling compartmentalized and bidirectional regulation of Akt phosphorylation.\",\n      \"evidence\": \"Co-IP of Epac-Akt-PP2A with functional phosphatase assay; co-IP of AKAP150-Epac-PKA-Akt in neurons with AKAP-disrupting peptides and siRNA\",\n      \"pmids\": [\"18550542\", \"18565730\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac1 vs Epac2 occupy the same or distinct AKAP complexes unclear\", \"Post-translational modifications regulating scaffold assembly not characterized\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linking Epac to CaMKII-dependent arrhythmogenesis and β-AR-induced hypertrophic gene program via Ras/calcineurin/CaMKII cemented a pro-pathological cardiac signaling axis downstream of cAMP that is distinct from PKA.\",\n      \"evidence\": \"Epac-selective agonist in Langendorff-perfused hearts with CaMKII inhibitor; Epac1 siRNA in adult cardiomyocytes with Ras/calcineurin/CaMKII inhibitors\",\n      \"pmids\": [\"18600344\", \"18323524\", \"20576488\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether chronic Epac inhibition is cardioprotective in heart failure models not tested at this stage\", \"Relative contribution of CaMKII vs calcineurin arm not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstration that EPAC1 controls endothelial angiogenesis via PI3K/Akt/eNOS, vascular relaxation via BKCa and endothelial SKCa/IKCa/NOS, and integrin-dependent progenitor cell homing established EPAC1 as a central regulator of vascular function.\",\n      \"evidence\": \"Epac1 siRNA suppressing Akt/eNOS with in vivo neovascularization; tension recording and Ca²⁺ spark imaging in mesenteric arteries; integrin affinity assays and hind limb ischemia model for progenitor homing\",\n      \"pmids\": [\"19385062\", \"23959673\", \"18032709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac1 is the dominant isoform in all vascular beds not established\", \"Structural basis for Epac-PI3K coupling unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defining the cAMP/Epac/Rap1/PLCε/IP3 cascade for acrosomal Ca²⁺ release during sperm exocytosis showed EPAC1 as the cAMP sensor for fertilization-relevant exocytosis, with Rab3A activated indirectly downstream.\",\n      \"evidence\": \"In vitro GEF assay showing no direct Epac activity on Rab3A; PLCε siRNA and Rap1-GTP pulldown in human sperm; TAT-cAMP sponge approach\",\n      \"pmids\": [\"19546222\", \"26704387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac1 or Epac2 is the dominant isoform in human sperm exocytosis not definitively resolved\", \"Direct visualization of Epac-Rap1-PLCε signalosome in sperm not achieved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Development of selective Epac inhibitors (ESI-09, CE3F4) with defined mechanisms of action provided critical pharmacological tools and confirmed that cellular phenotypes attributed to Epac (migration, Rap1 activation, insulin secretion) are on-target.\",\n      \"evidence\": \"CE3F4 uncompetitive kinetics in cell-free GEF assay; ESI-09 blocking Rap1 activation and Akt phosphorylation with functional readouts in cancer and β-cells\",\n      \"pmids\": [\"23139415\", \"23066090\", \"25183009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Off-target effects of ESI-09 at higher concentrations debated\", \"In vivo pharmacokinetics and selectivity of these inhibitors not fully characterized\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"EPAC1 knockout neurons displaying axon specification defects, rescued by pharmacological activation, established a non-redundant role for EPAC1-Rap1b in neuronal polarity, extending its function beyond growth cone guidance to fundamental cell fate decisions.\",\n      \"evidence\": \"EPAC1 KO mouse neurons, shRNA knockdown, Epac-selective agonist inducing supernumerary axons with mature markers (ankyrin G, synaptophysin, vGLUT1)\",\n      \"pmids\": [\"26269639\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EPAC2 compensates partially in EPAC1 KO neurons not tested\", \"Downstream effectors linking Rap1b to polarity determinants (Par complex, etc.) not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mapping the complete β-AR-cAMP-Epac-PI3K-Akt-NOS1-CaMKII series pathway for SR Ca²⁺ leak, alongside Epac-Rap1 control of tight junctions and retinal vascular permeability, unified cardiac and vascular pathophysiology under EPAC1 signaling.\",\n      \"evidence\": \"Ca²⁺ spark frequency and FRET-CaMKII reporter with sequential pharmacological inhibitors in cardiomyocytes; Rap1B siRNA and Epac agonist/antagonist with in vivo retinal permeability\",\n      \"pmids\": [\"28476660\", \"29158262\", \"27855271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NOS1 vs NOS3 selectivity is cell-type dependent unclear\", \"Structural basis for Epac-PI3K coupling in cardiomyocytes not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"EPAC1 was placed downstream of PGE2/EP2 receptors in macrophage IL-33 production, revealing an innate immune signaling function and expanding EPAC's role to inflammatory cytokine regulation.\",\n      \"evidence\": \"EP2 and mPGES-1 KO macrophages, EPAC knockdown, EPAC-selective agonist, in vivo Alternaria lung inflammation model\",\n      \"pmids\": [\"28341741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EPAC1 regulates other alarmin cytokines besides IL-33 not investigated\", \"Downstream Rap1 effectors mediating IL-33 transcription not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the isoform-specific contributions of EPAC1 vs EPAC2 across tissues, the structural basis of EPAC1 scaffolding with AKAP/PP2A/PI3K complexes, and whether chronic pharmacological EPAC1 inhibition is therapeutically viable in cardiac or vascular disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of full-length active EPAC1 in complex with Rap1 and scaffold partners\", \"Therapeutic window for EPAC1 inhibition in vivo not established\", \"Isoform-specific knockout phenotype comparison across cardiovascular, neuronal, and immune systems incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4, 16, 27, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 12, 28, 33, 36]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 4, 12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 24, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 12, 13, 29, 35]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [10, 34, 36]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [8, 25, 30]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [37]}\n    ],\n    \"complexes\": [\n      \"Epac1-Akt-PP2A complex\",\n      \"AKAP150-Epac-PKA-Akt complex\",\n      \"Epac-SUR1 complex\"\n    ],\n    \"partners\": [\n      \"RAP1A\",\n      \"RAP1B\",\n      \"RRAS\",\n      \"ABCC8\",\n      \"AKT1\",\n      \"PPP2CA\",\n      \"AKAP5\",\n      \"MAP1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}